Health Law Daily
A complete, daily report of breaking news in health law.
Breaking news and expert analysis on health law and compliance developments
What good is the right knowledge if it’s at the wrong time?
A complete daily report of the news that affects your world
- View full summaries of federal and state court decisions
- Access full text of legislative and regulatory developments
- Customize your daily email by topic and/or jurisdiction
- Search archives for stories of interest
Not just news – the right news
- Get expert analysis written by subject matter specialists—created by attorneys for attorneys
- Track law firms and organizations in the headlines with our new “Who’s in the News” feature
- Promote your firm with our permissions policy
24/7 access for a 24/7 world
- Forward information with special copyright permissions, encouraging collaboration between counsel and colleagues
- Save time with mobile apps for your iPhone, iPad, or Android
- Access all links from any mobile device without being prompted for user name and password
Allegations of an Illegal kickback scheme involving diabetes supplies survives motion to dismiss
While fraud plaintiffs are required to plead specifics, when they allege a wide-ranging scheme involving numerous systematic misrepresentations, they are allowed to plead representative samples...
Coronavirus Aid, Relief, and Economic Security Act (CARES Act) impacts health industry, health law
Highlights of the CARES Act that relate to the health industry and health law are outlined.
FDA eases restrictions on face masks and respirators amid COVID-19 crisis
The FDA sets forth a policy to expand the availability of face masks and respirators and invites manufacturers to offer solutions.
Medicare inpatients switched to observation status were deprived of due process
Hospital utilization review staff changes based on mandatory CMS standards, without there being a mechanism to challenge such decisions, constituted a deprivation of a property interest in Medicare...
Drug manufacturer entitled to retroactive adjustment of rebates it paid to states
The Medicaid Drug Rebate Program in effect during the relevant period should have been construed by CMS to treat duplicate drugs subject to the lower rebate rate.